Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,254
  • Shares Outstanding, K 32,476
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,940 K
  • EBIT $ -36 M
  • EBITDA $ -35 M
  • 60-Month Beta -0.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 256.43% ( -20.77%)
  • Historical Volatility 52.17%
  • IV Percentile 88%
  • IV Rank 62.64%
  • IV High 405.77% on 11/18/24
  • IV Low 6.03% on 04/15/24
  • Put/Call Vol Ratio 1.28
  • Today's Volume 360
  • Volume Avg (30-Day) 405
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 8,698
  • Open Int (30-Day) 14,379

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.79 +5.15%
on 11/15/24
6.07 -34.47%
on 10/21/24
-2.08 (-34.32%)
since 10/18/24
3-Month
3.79 +5.15%
on 11/15/24
8.33 -52.22%
on 09/19/24
-1.27 (-24.19%)
since 08/20/24
52-Week
0.77 +416.88%
on 12/05/23
14.30 -72.17%
on 05/16/24
+3.09 (+347.14%)
since 11/20/23

Most Recent Stories

More News
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

CADL : 3.98 (-0.25%)
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024

CADL : 3.98 (-0.25%)
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma

CADL : 3.98 (-0.25%)
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC)

CADL : 3.98 (-0.25%)
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting

CADL : 3.98 (-0.25%)
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 0.9985 (-5.80%)
HALO : 45.76 (+2.12%)
CADL : 3.98 (-0.25%)
MRUS : 42.93 (-1.29%)
RHHBY : 35.1300 (-0.79%)
ONC.TO : 1.40 (-5.41%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.1300 (-0.79%)
HALO : 45.76 (+2.12%)
CADL : 3.98 (-0.25%)
MRUS : 42.93 (-1.29%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 35.1300 (-0.79%)
ONCY : 0.9985 (-5.80%)
VSTM : 3.79 (-4.29%)
CADL : 3.98 (-0.25%)
FGEN : 0.3500 (unch)
REGN : 743.35 (-0.17%)
ONC.TO : 1.40 (-5.41%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.1300 (-0.79%)
VSTM : 3.79 (-4.29%)
CADL : 3.98 (-0.25%)
FGEN : 0.3500 (unch)
REGN : 743.35 (-0.17%)
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 0.9985 (-5.80%)
CADL : 3.98 (-0.25%)
AZN : 63.20 (-0.94%)
MRUS : 42.93 (-1.29%)
LTRN : 2.94 (-4.55%)
ONC.TO : 1.40 (-5.41%)

Business Summary

Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company's product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 4.26
2nd Resistance Point 4.18
1st Resistance Point 4.08
Last Price 3.98
1st Support Level 3.90
2nd Support Level 3.82
3rd Support Level 3.72

See More

52-Week High 14.30
Fibonacci 61.8% 9.13
Fibonacci 50% 7.53
Fibonacci 38.2% 5.94
Last Price 3.98
52-Week Low 0.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar